Sanofi makes $69/share Genzyme offer public

PHILADELPHIA, Aug 29 (BestGrowthStock) – France’s Sanofi-Aventis
(SASY.PA: ) on Sunday publicly disclosed its $18.5 billion,
$69-per-share cash offer for Genzyme Corp (GENZ.O: ) after
failing to engage the biotechnology company in merger talks.

Sanofi makes $69/share Genzyme offer public